Pieris Pharmaceuticals (PIRS) Priced

Developing a therapy for iron deficiency in anemic patients with chronic kidney disease.

Health Care - Biotechnology

IPO Performance
Latest Trade $2.04 0.00 (0.0%)
First Day Return 0.0%
Return from IPO -25.8%
 
Pieris Pharmaceuticals IPO News more
  • .
IPO Data
IPO File Date 06/09/2015
Offer Price $2.75
Price Range $2.75 - $2.75
Offer Shares (mm) 9.1
Deal Size ($mm) 25
 
IPO Data
IPO Date 06/29/2015
Offer Price $2.75
Price Range $2.75 - $2.75
Offer Shares (mm) 9.1
Deal Size ($mm) $25
 
Underwriters
more
Business Overview
Developing a therapy for iron deficiency in anemic patients with chronic kidney disease.
Developing a therapy for iron deficiency in anemic patients with chronic kidney disease.
more
Company Data
Headquarters Freising-Weihenstephan, , Germany
Founded 2000
Employees 30
Website www.pieris.com
 

Performance vs. IPO Index (IPOUSA)